If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Technical Reports Series No. 432
English STI/DOC/010/432 | 92-0-109304-7
71 pages | € 40.00 | Date published: 2004Radionuclides continue to play an important role in diagnostic and therapeutic applications in modern nuclear medicine. Many of these radionuclides are produced using cyclotron accelerators, and the corresponding laboratory production methodologies and technologies are subject to constant improvements.
This publication summarizes the laboratory protocols developed over a three year period for the production of radionuclides using solid target technology, in particular thallium-201, iodine-123, iodine-124 and palladium-103, which are important radioisotopes for use in medical diagnosis and therapy. This publication is a suitable guide for radioisotope laboratories, cyclotron and radiochemical production facilities, and will be of interest to those dealing with production and applications of radioisotopes and radiopharmaceuticals for nuclear medicine and industrial purposes.
A CD-ROM is included.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
